Search

Maria Marvich

Examiner (ID: 9363)

Most Active Art Unit
1633
Art Unit(s)
1633, 1634, 1631, 1636
Total Applications
1459
Issued Applications
618
Pending Applications
253
Abandoned Applications
627

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 22790 [patent_doc_number] => 07799904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Gilvocarcin gene cluster, recombinant production and use thereof' [patent_app_type] => utility [patent_app_number] => 10/866089 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 9 [patent_no_of_words] => 13444 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799904.pdf [firstpage_image] =>[orig_patent_app_number] => 10866089 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/866089
Gilvocarcin gene cluster, recombinant production and use thereof Jun 13, 2004 Issued
Array ( [id] => 7103496 [patent_doc_number] => 20050106222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method to increase protein production in culture' [patent_app_type] => utility [patent_app_number] => 10/864348 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12892 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106222.pdf [firstpage_image] =>[orig_patent_app_number] => 10864348 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/864348
Method to increase protein production in culture Jun 9, 2004 Abandoned
Array ( [id] => 5921304 [patent_doc_number] => 20060239988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Neuronal regeneration and compound administration methods' [patent_app_type] => utility [patent_app_number] => 10/559871 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 33647 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239988.pdf [firstpage_image] =>[orig_patent_app_number] => 10559871 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559871
Neuronal regeneration and compound administration methods Jun 8, 2004 Abandoned
Array ( [id] => 7056432 [patent_doc_number] => 20050277607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Compositions and methods for regulating peptidyltransferase activity and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/864079 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13251 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277607.pdf [firstpage_image] =>[orig_patent_app_number] => 10864079 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/864079
Compositions and methods for regulating peptidyltransferase activity and uses thereof Jun 8, 2004 Abandoned
Array ( [id] => 7428640 [patent_doc_number] => 20040209364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'AAV vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection' [patent_app_type] => new [patent_app_number] => 10/485937 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5097 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209364.pdf [firstpage_image] =>[orig_patent_app_number] => 10485937 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/485937
AAV vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection Jun 8, 2004 Abandoned
Array ( [id] => 6971680 [patent_doc_number] => 20050037390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Methods and compositions for modulating erythropoietin expression' [patent_app_type] => utility [patent_app_number] => 10/862013 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14850 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037390.pdf [firstpage_image] =>[orig_patent_app_number] => 10862013 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862013
Methods and compositions for modulating erythropoietin expression Jun 3, 2004 Abandoned
Array ( [id] => 5252745 [patent_doc_number] => 20070134201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Archaeon expression system' [patent_app_type] => utility [patent_app_number] => 10/559583 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8193 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134201.pdf [firstpage_image] =>[orig_patent_app_number] => 10559583 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559583
Archaeon expression system Jun 1, 2004 Issued
Array ( [id] => 6996257 [patent_doc_number] => 20050136035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site' [patent_app_type] => utility [patent_app_number] => 10/857498 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22270 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136035.pdf [firstpage_image] =>[orig_patent_app_number] => 10857498 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857498
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site May 31, 2004 Abandoned
Array ( [id] => 7426758 [patent_doc_number] => 20040229833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Therapeutic use of cis-element decays in vivo' [patent_app_type] => new [patent_app_number] => 10/850994 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4274 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229833.pdf [firstpage_image] =>[orig_patent_app_number] => 10850994 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850994
Therapeutic use of cis-element decays in vivo May 19, 2004 Abandoned
Array ( [id] => 5034161 [patent_doc_number] => 20070098700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Synthetic mammalian retotransposon gene' [patent_app_type] => utility [patent_app_number] => 10/558804 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 9173 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098700.pdf [firstpage_image] =>[orig_patent_app_number] => 10558804 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558804
Synthetic mammalian retrotransposon gene May 17, 2004 Issued
Array ( [id] => 7427499 [patent_doc_number] => 20040209247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'E1-revertant-free adenoviral composition' [patent_app_type] => new [patent_app_number] => 10/844133 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11663 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209247.pdf [firstpage_image] =>[orig_patent_app_number] => 10844133 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/844133
E1-revertant-free adenoviral composition May 11, 2004 Abandoned
Array ( [id] => 7089055 [patent_doc_number] => 20050009168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Methods and apparatus for Adeno associated virus purification' [patent_app_type] => utility [patent_app_number] => 10/843718 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3916 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009168.pdf [firstpage_image] =>[orig_patent_app_number] => 10843718 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/843718
Methods and apparatus for Adeno associated virus purification May 10, 2004 Abandoned
Array ( [id] => 7103833 [patent_doc_number] => 20050106559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Viral vector' [patent_app_type] => utility [patent_app_number] => 10/841603 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 48661 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10841603 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/841603
Viral vector May 6, 2004 Issued
Array ( [id] => 7060593 [patent_doc_number] => 20050002953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'SARS-coronavirus virus-like particles and methods of use' [patent_app_type] => utility [patent_app_number] => 10/839729 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15334 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002953.pdf [firstpage_image] =>[orig_patent_app_number] => 10839729 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/839729
SARS-coronavirus virus-like particles and methods of use May 3, 2004 Abandoned
Array ( [id] => 7348679 [patent_doc_number] => 20040248301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences' [patent_app_type] => new [patent_app_number] => 10/837029 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32635 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248301.pdf [firstpage_image] =>[orig_patent_app_number] => 10837029 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/837029
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences Apr 29, 2004 Issued
Array ( [id] => 7252697 [patent_doc_number] => 20050142617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'High bone mass gene of 11q13.3' [patent_app_type] => utility [patent_app_number] => 10/834377 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39668 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142617.pdf [firstpage_image] =>[orig_patent_app_number] => 10834377 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/834377
High bone mass gene of 11q13.3 Apr 28, 2004 Abandoned
Array ( [id] => 7061121 [patent_doc_number] => 20050003482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site' [patent_app_type] => utility [patent_app_number] => 10/831302 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19426 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003482.pdf [firstpage_image] =>[orig_patent_app_number] => 10831302 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831302
Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site Apr 25, 2004 Issued
Array ( [id] => 121216 [patent_doc_number] => 07709224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site' [patent_app_type] => utility [patent_app_number] => 10/831304 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 22811 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709224.pdf [firstpage_image] =>[orig_patent_app_number] => 10831304 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831304
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site Apr 25, 2004 Issued
Array ( [id] => 5759591 [patent_doc_number] => 20060210536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Methods and compositions for inhibiting stat signaling pathways' [patent_app_type] => utility [patent_app_number] => 10/553160 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32034 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210536.pdf [firstpage_image] =>[orig_patent_app_number] => 10553160 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553160
Methods and compositions for inhibiting stat signaling pathways Apr 18, 2004 Abandoned
Array ( [id] => 7010832 [patent_doc_number] => 20050064548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Yeast ectopically expressing abnormally processed proteins and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/826157 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14519 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064548.pdf [firstpage_image] =>[orig_patent_app_number] => 10826157 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/826157
Yeast ectopically expressing abnormally processed proteins and uses therefor Apr 15, 2004 Abandoned
Menu